Literature DB >> 20461755

HMGA1 and HMGA2 rearrangements in mass-forming endometriosis.

Fabiola Medeiros1, Ana R Araujo, Michele R Erickson-Johnson, Purna C Kashyap, Paola Dal Cin, Marisa Nucci, Xiaoke Wang, Debra A Bell, Andre M Oliveira.   

Abstract

Endometriosis is a common gynecologic disorder characterized by ectopic endometrium associated with pelvic pain and infertility. The pathogenesis of endometriosis is unclear, and several genetic, endocrine, immune, and environmental agents have been studied as putative causative factors. However, consistent somatic genetic alterations have not been identified. Rarely, endometriosis presents as a mass lesion with an infiltrative pattern reminiscent of malignancy. We describe cytogenetic and molecular cytogenetic findings of mass-forming endometriosis. The index case of pulmonary endometriosis underwent conventional and molecular cytogenetics analysis. In addition, 16 cases of mass-forming endometriosis, 11 cases of usual endometriosis, and six endometriomas were investigated by fluorescence in situ hybridization (FISH) for HMGA1 and HMGA2 loci, performed on paraffin-embedded thin tissue sections with custom-designed probes. The index patient had an endometriotic lung nodule, with a 46,XX, t(5;6)(q13;p21) karyotype and HMGA1 rearrangement by FISH. A second patient had decidualized endometriosis forming a large abdominal mass and HMGA1 rearrangement by FISH. Of the 15 other cases of mass-forming endometriosis, one had HMGA1 rearrangement and two had HMGA2 rearrangement. The rearrangements were found in the stromal component exclusively. None of the usual endometriosis cases or endometriomas had HMGA1 or HMGA2 rearrangements. In conclusion, mass-forming endometriosis is an uncommon subset of endometriosis that harbors HMGA1 or HMGA2 rearrangements in up to 29% of cases. The present findings support the concept that endometriosis is clonal and that rearrangement of HMGA genes likely contributes to its pathogenesis. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20461755     DOI: 10.1002/gcc.20772

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  9 in total

1.  Silencing of HMGA1 expression by RNA interference suppresses growth of osteogenic sarcoma.

Authors:  Shaohui Yuan; Qi Pan; Chunjiang Fu; Zhenggang Bi
Journal:  Mol Cell Biochem       Date:  2011-05-15       Impact factor: 3.396

2.  Genomic imbalances in benign metastasizing leiomyoma: characterization by conventional karyotypic, fluorescence in situ hybridization, and whole genome SNP array analysis.

Authors:  Joslin M Bowen; Justin M Cates; Shera Kash; Doha Itani; Adriana Gonzalez; Dali Huang; Andre Oliveira; Julia A Bridge
Journal:  Cancer Genet       Date:  2012-05

3.  Stromal epigenetic dysregulation is sufficient to initiate mouse prostate cancer via paracrine Wnt signaling.

Authors:  Yang Zong; Jiaoti Huang; Devipriya Sankarasharma; Teppei Morikawa; Masashi Fukayama; Jonathan I Epstein; Kiran K Chada; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-26       Impact factor: 11.205

4.  Loss of stromal CD73 expression plays a role in pathogenesis of polypoid endometriosis.

Authors:  Ali Yilmaz Altay; Ekrem Yavuz; Aysel Bayram; Cenk Yasa; Suleyman Engin Akhan; Samet Topuz; Semen Onder
Journal:  Arch Gynecol Obstet       Date:  2021-01-12       Impact factor: 2.344

Review 5.  Somatic Genomic Events in Endometriosis: Review of the Literature and Approach to Phenotyping.

Authors:  Paul J Yong; Aline Talhouk; Michael S Anglesio
Journal:  Reprod Sci       Date:  2021-01-19       Impact factor: 3.060

6.  HMGA2 Expression in Renal Carcinoma and its Clinical Significance.

Authors:  Ying Liu; Qi-Zhong Fu; Lin Pu; Qing-Guo Meng; Xian-Feng Liu; Sheng-Fang Dong; Jian-Xun Yang; Guang-Yao Lv
Journal:  J Med Biochem       Date:  2015-07-14       Impact factor: 3.402

7.  Effect of RNA interference of the expression of HMGA2 on the proliferation and invasion ability of ACHN renal cell carcinoma cells.

Authors:  Ying Liu; Qi-Zhong Fu; Lin Pu; Ling-Ling Song; Yi-Yun Wang; Jing Liu; Zhen-Long Wang; Zi-Ming Wang
Journal:  Mol Med Rep       Date:  2017-08-16       Impact factor: 2.952

8.  Fusion of the TBL1XR1 and HMGA1 genes in splenic hemangioma with t(3;6)(q26;p21).

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Bodil Bjerkehagen; Ingvild Lobmaier; Sverre Heim
Journal:  Int J Oncol       Date:  2015-12-28       Impact factor: 5.650

9.  Genomic profiling of pelvic genital type leiomyosarcoma in a woman with a germline CHEK2:c.1100delC mutation and a concomitant diagnosis of metastatic invasive ductal breast carcinoma.

Authors:  My Linh Thibodeau; Caralyn Reisle; Eric Zhao; Lee Ann Martin; Yazeed Alwelaie; Karen L Mungall; Carolyn Ch'ng; Ruth Thomas; Tony Ng; Stephen Yip; Howard J Lim; Sophie Sun; Sean S Young; Aly Karsan; Yongjun Zhao; Andrew J Mungall; Richard A Moore; Daniel J Renouf; Karen Gelmon; Yussanne P Ma; Malcolm Hayes; Janessa Laskin; Marco A Marra; Kasmintan A Schrader; Steven J M Jones
Journal:  Cold Spring Harb Mol Case Stud       Date:  2017-09-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.